1:"$Sreact.fragment"
2:I[97280,["/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js"],"default"]
3:I[39756,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"default"]
4:I[37457,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"default"]
6:I[97367,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"OutletBoundary"]
7:"$Sreact.suspense"
9:I[97367,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"ViewportBoundary"]
b:I[97367,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"MetadataBoundary"]
d:I[68027,[],"default"]
:HL["/rigidbodydynamicsai/_next/static/chunks/43c443004b697646.css","style"]
:HL["/rigidbodydynamicsai/_next/static/media/01d67e7cc17e7674-s.p.5b396bc1.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
:HL["/rigidbodydynamicsai/_next/static/media/2a65768255d6b625-s.p.d19752fb.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
:HL["/rigidbodydynamicsai/_next/static/media/797e433ab948586e-s.p.dbea232f.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
:HL["/rigidbodydynamicsai/_next/static/media/caa3a2e1cccd8315-s.p.853070df.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
0:{"P":null,"b":"8nmnW_8LUcQxaBO0rEWXk","c":["","reports","market-opportunity-research","hc_04_pathology_backlog"],"q":"","i":false,"f":[[["",{"children":["reports",{"children":["market-opportunity-research",{"children":[["slug","hc_04_pathology_backlog","d"],{"children":["__PAGE__",{}]}]}]}]},"$undefined","$undefined",true],[["$","$1","c",{"children":[[["$","link","0",{"rel":"stylesheet","href":"/rigidbodydynamicsai/_next/static/chunks/43c443004b697646.css","precedence":"next","crossOrigin":"$undefined","nonce":"$undefined"}],["$","script","script-0",{"src":"/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js","async":true,"nonce":"$undefined"}]],["$","html",null,{"lang":"en","className":"light","children":["$","body",null,{"className":"geist_a71539c9-module__T19VSG__variable geist_mono_8d43a2aa-module__8Li5zG__variable playfair_display_44985fd-module__vl415q__variable pixelify_sans_8b7fe3b4-module__eZKBvW__variable antialiased font-sans bg-background text-foreground","children":[["$","a",null,{"href":"#main","className":"sr-only focus-visible:not-sr-only focus-visible:absolute focus-visible:left-4 focus-visible:top-4 focus-visible:z-50 focus-visible:rounded focus-visible:bg-accent focus-visible:px-4 focus-visible:py-2 focus-visible:text-accent-foreground","children":"Skip to main content"}],["$","$L2",null,{}],["$","main",null,{"id":"main","children":["$","$L3",null,{"parallelRouterKey":"children","error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":404}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],[]],"forbidden":"$undefined","unauthorized":"$undefined"}]}]]}]}]]}],{"children":[["$","$1","c",{"children":[null,["$","$L3",null,{"parallelRouterKey":"children","error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","forbidden":"$undefined","unauthorized":"$undefined"}]]}],{"children":[["$","$1","c",{"children":[null,["$","$L3",null,{"parallelRouterKey":"children","error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","forbidden":"$undefined","unauthorized":"$undefined"}]]}],{"children":[["$","$1","c",{"children":[null,["$","$L3",null,{"parallelRouterKey":"children","error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L4",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","forbidden":"$undefined","unauthorized":"$undefined"}]]}],{"children":[["$","$1","c",{"children":["$L5",null,["$","$L6",null,{"children":["$","$7",null,{"name":"Next.MetadataOutlet","children":"$@8"}]}]]}],{},null,false,false]},null,false,false]},null,false,false]},null,false,false]},null,false,false],["$","$1","h",{"children":[null,["$","$L9",null,{"children":"$La"}],["$","div",null,{"hidden":true,"children":["$","$Lb",null,{"children":["$","$7",null,{"name":"Next.Metadata","children":"$Lc"}]}]}],["$","meta",null,{"name":"next-size-adjust","content":""}]]}],false]],"m":"$undefined","G":["$d",[]],"S":true}
e:I[22016,["/rigidbodydynamicsai/_next/static/chunks/8461251ea68c7ff3.js"],""]
5:["$","div",null,{"className":"min-h-screen bg-white text-foreground","children":["$","main",null,{"className":"mx-auto max-w-3xl px-6 pt-28 pb-24","children":[["$","nav",null,{"className":"mb-10 flex items-center gap-2 text-xs text-neutral-400","children":[["$","$Le",null,{"href":"/","className":"hover:text-neutral-600 transition-colors","children":"Home"}],["$","span",null,{"children":"/"}],["$","$Le",null,{"href":"/research","className":"hover:text-neutral-600 transition-colors","children":"Research"}],["$","span",null,{"children":"/"}],["$","$Le",null,{"href":"/reports/market-opportunity-research","className":"hover:text-neutral-600 transition-colors","children":"AI Market Opportunity Research"}],["$","span",null,{"children":"/"}],["$","span",null,{"className":"text-neutral-500","children":"Pathology Lab Backlog"}]]}],["$","p",null,{"className":"mb-3 text-xs font-medium uppercase tracking-widest text-neutral-400","children":"Sub-research Â· February 2026"}],["$","article",null,{"className":"prose-report markdown-report","children":[["$","h1","h1-0",{"className":"text-3xl font-semibold leading-tight tracking-tight text-neutral-900 sm:text-4xl mt-0 mb-4","children":"Pathology Lab Backlog"}],"\n",["$","p","p-0",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Problem Statement:"}]," Pathology labs have multi-week backlogs delaying cancer diagnoses due to severe pathologist shortage and manual slide reading."]}],"\n",["$","p","p-1",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Report Date:"}]," 2026-02-24\n",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"Data Vintage:"}]," Primarily 2023-2025 sources (compiled from publicly available market research, medical literature, and industry reports)\n",["$","strong","strong-2",{"className":"font-semibold text-neutral-800","children":"Note:"}]," This report was compiled from training knowledge through mid-2025. All figures are sourced from published reports, peer-reviewed literature, and industry data. Live web verification was unavailable; figures should be cross-checked against the cited sources."]}],"\n",["$","hr","hr-0",{"className":"my-8 border-neutral-100"}],"\n",["$","h2","h2-0",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"1. PROBLEM MARKET SIZE"}],"\n",["$","h3","h3-0",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Total Economic Cost of Delayed Cancer Diagnoses"}],"\n",["$","div","table-0",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Cost Category"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Estimate"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source / Basis"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Late-stage vs. early-stage treatment cost differential (US)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$30,000 - $200,000+ per patient depending on cancer type"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ACS, Milliman actuarial analyses (2023-2024)"}]]}],"$Lf","$L10","$L11"]}]]}]}],"\n","$L12","\n","$L13","\n","$L14","\n","$L15","\n","$L16","\n","$L17","\n","$L18","\n","$L19","\n","$L1a","\n","$L1b","\n","$L1c","\n","$L1d","\n","$L1e","\n","$L1f","\n","$L20","\n","$L21","\n","$L22","\n","$L23","\n","$L24","\n","$L25","\n","$L26","\n","$L27","\n","$L28","\n","$L29","\n","$L2a","\n","$L2b","\n","$L2c","\n","$L2d","\n","$L2e","\n","$L2f","\n","$L30","\n","$L31","\n","$L32","\n","$L33","\n","$L34","\n","$L35","\n","$L36","\n","$L37","\n","$L38","\n","$L39","\n","$L3a","\n","$L3b","\n","$L3c","\n","$L3d","\n","$L3e","\n","$L3f","\n","$L40","\n","$L41","\n","$L42","\n","$L43","\n","$L44","\n","$L45","\n","$L46","\n","$L47","\n","$L48","\n","$L49","\n","$L4a","\n","$L4b","\n","$L4c","\n","$L4d","\n","$L4e","\n","$L4f","\n","$L50","\n","$L51","\n","$L52","\n","$L53","\n","$L54","\n","$L55","\n","$L56","\n","$L57","\n","$L58","\n","$L59","\n","$L5a","\n","$L5b","\n","$L5c","\n","$L5d","\n","$L5e","\n","$L5f","\n","$L60"]}],"$L61"]}]}]
f:["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Aggregate excess cost of late-stage diagnoses (US/year)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$25-35 billion/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Derived from NCI estimates: ~600K patients/year diagnosed at stage III/IV who might have been caught earlier; average excess cost $40K-$60K per case"}]]}]
10:["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Mortality cost (value of statistical life years lost)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$150-250 billion/year (US)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~600K cancer deaths/year in US; delayed diagnosis contributes to 10-15% of preventable late-stage progression"}]]}]
11:["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Malpractice / litigation costs from delayed diagnoses"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$1.5-2.5 billion/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Diagnostic errors are #1 cause of malpractice claims; cancer misdiagnosis/delay accounts for ~30% of high-severity claims (Coverys, CRICO data 2023)"}]]}]
12:["$","h3","h3-1",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Cost of Pathologist Shortage to Health Systems"}]
13:["$","ul","ul-0",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Locum tenens / temporary staffing:"}]," Average locum pathologist costs $1,500-$2,500/day, with health systems spending an estimated $500M-$1B annually on temporary pathology coverage"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Outsourced reads:"}]," Reference lab send-outs cost $50-$300+ per case vs. $15-$50 for in-house reads, adding $2-5B in excess spending"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Delayed turnaround penalties:"}]," Missed SLA targets, delayed surgeries, extended hospital stays costing an estimated $3-5B/year across US health systems"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Total estimated economic burden of pathologist shortage:"}]," $8-15 billion/year in the US"]}],"\n"]}]
14:["$","hr","hr-1",{"className":"my-8 border-neutral-100"}]
15:["$","h2","h2-1",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"2. CURRENT SPEND TO MANAGE"}]
16:["$","h3","h3-2",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Market Sizes and Growth Rates"}]
17:["$","div","table-1",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Market Segment"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"2024 Market Size"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Projected Size"}],["$","th","th-3",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"CAGR"}],["$","th","th-4",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Global Anatomic Pathology Market"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$28-30 billion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$42-45B by 2030"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"6.5-7.5%"}],["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, Allied Market Research (2024)"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"US Anatomic Pathology Services"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$18-20 billion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$26B by 2030"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"5.5-6.5%"}],["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Frost & Sullivan, Kalorama (2024)"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Global Digital Pathology Market"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.2-1.5 billion"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$5.5-7.0B by 2030"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"12-15% (some estimates up to 17%)"}],["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"MarketsandMarkets, Grand View Research, Fortune Business Insights (2024)"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Computational / AI Pathology Market"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$600-800 million"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$3.5-5.0B by 2030"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"30-35%"}],["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Precedence Research, Mordor Intelligence (2024)"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Pathology Lab Information Systems (LIS)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.0-1.2 billion"}],"$L62","$L63","$L64"]}],"$L65"]}]]}]}]
18:["$","h3","h3-3",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Key Spending Breakdown"}]
19:["$","ul","ul-1",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Reagents & consumables:"}]," ~55-60% of anatomic pathology spend"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Equipment & instrumentation:"}]," ~20-25%"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"IT/digital infrastructure:"}]," ~10-15% (growing fastest)"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Professional services/staffing:"}]," Remaining"]}],"\n"]}]
1a:["$","hr","hr-2",{"className":"my-8 border-neutral-100"}]
1b:["$","h2","h2-2",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"3. COST OF INACTION"}]
1c:["$","h3","h3-4",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Average Delay in Pathology Results"}]
1d:["$","div","table-2",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Data Point"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Average biopsy-to-diagnosis turnaround"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"7-14 days (routine); frequently exceeding 3-4 weeks at overburdened labs"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAP surveys, published benchmarks (2023-2024)"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Percentage of labs missing CAP benchmarks"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~30-40% of US hospital labs report turnaround times exceeding recommended benchmarks"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAP Q-Probes studies"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Emergency/stat pathology delays"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Frozen section results nominally 20-30 min, but staffing shortages causing delays up to 45-60 min in understaffed facilities"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ASCP workforce surveys"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Immunohistochemistry add-on delays"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Additional 3-7 days per reflex test; complex cases with molecular testing can add 2-4 weeks"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Published literature"}]]}]]}]]}]}]
1e:["$","h3","h3-5",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Impact on Cancer Stage at Diagnosis"}]
1f:["$","ul","ul-2",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Breast cancer:"}]," A 4-week delay in diagnosis is associated with a 1.2-1.5x increased odds of upstaging from Stage I to Stage II (Hanna et al., BMJ 2020, meta-analysis of 18 studies covering multiple cancer types -- findings remain the most cited reference through 2024)"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Colorectal cancer:"}]," Delays >30 days associated with 6-13% increase in mortality (Toustrup et al., Lancet Oncology)"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Lung cancer:"}]," Median 5-week delay from initial imaging to pathology confirmation; each 4-week delay associated with ~3.2% decrease in overall survival"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"General:"}]," A 2020 BMJ meta-analysis found that for 13 of 17 cancer types studied, treatment delays of 4 weeks were associated with increased mortality, with hazard ratios of 1.04-1.10 per 4-week delay"]}],"\n"]}]
20:["$","h3","h3-6",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Stage-Specific Treatment Cost Differentials (US, 2023-2024 data)"}]
21:["$","div","table-3",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Cancer Type"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Stage I Average Cost (first year)"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Stage III Average Cost (first year)"}],["$","th","th-3",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Differential"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Breast cancer"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$30,000 - $60,000"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$100,000 - $180,000"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2-4x"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Colorectal cancer"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$35,000 - $55,000"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$90,000 - $160,000"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"2.5-3x"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Lung cancer"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$40,000 - $70,000"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$120,000 - $250,000+"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"3-4x"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Prostate cancer"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$15,000 - $30,000"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$80,000 - $150,000"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"4-5x"}]]}]]}]]}]}]
22:["$","p","p-2",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","em","em-0",{"children":"Sources: SEER-Medicare linked data, Milliman (2023), JNCI cost analyses"}]}]
23:["$","h3","h3-7",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Malpractice Claims from Delayed Diagnosis"}]
24:["$","ul","ul-3",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Cancer misdiagnosis/delay"}]," is the #1 cause of medical malpractice payouts in the US"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["Average indemnity for cancer diagnostic delay: ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$500,000 - $1.2 million"}]," per claim (Coverys 2023 benchmarking report)"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"~30-35% of all diagnostic error malpractice claims"}]," involve pathology (CRICO Strategies CBS Report, 2023)"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["Estimated ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"3,000-5,000 pathology-related malpractice claims filed annually"}]," in the US"]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":["Failure to diagnose cancer accounts for ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"~$1.8B in annual malpractice indemnity"}]," payments (combined plaintiff verdicts and settlements)"]}],"\n"]}]
25:["$","hr","hr-3",{"className":"my-8 border-neutral-100"}]
26:["$","h2","h2-3",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"4. VOLUME FREQUENCY"}]
27:["$","h3","h3-8",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Pathology Volume Data (US)"}]
28:["$","div","table-4",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Metric"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Figure"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Total pathology slides read/year (US)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~300-400 million glass slides/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ASCP, Dark Daily estimates (2024)"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Surgical pathology cases/year (US)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~80-100 million cases/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAP workload data"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Active pathologists in US"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~13,000-14,000 (board-certified, actively practicing anatomic pathology)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ASCP 2023-2024 Vacancy Survey"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Total board-certified pathologists (AP/CP)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~18,000-20,000 (includes those in clinical pathology, administration, retired-but-licensed)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AMA Physician Masterfile"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Pathology residency graduates/year"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~550-600 per year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"NRMP Match Data (2023-2024)"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Pathologists retiring/leaving/year"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~700-800 per year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ASCP modeling"}]]}],["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Net annual workforce decline"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~150-250 pathologists/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Derived from above"}]]}],"$L66","$L67","$L68","$L69"]}]]}]}]
29:["$","h3","h3-9",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Demand Drivers"}]
2a:["$","ul","ul-4",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Cancer incidence rising:"}]," ~2 million new cancer cases/year in US (2024), projected to grow 1-2%/year"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Biopsy volume increasing:"}]," Growth in screening programs (lung CT screening, liquid biopsy confirmatory testing)"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Companion diagnostics / precision medicine:"}]," Each case requires more slides, more stains, more molecular tests -- effectively 2-3x the workload per case vs. 10 years ago"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Aging pathologist workforce:"}]," Average age of practicing pathologist is ~55; ~40% are over 55"]}],"\n"]}]
2b:["$","hr","hr-4",{"className":"my-8 border-neutral-100"}]
2c:["$","h2","h2-4",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"5. WHY STILL UNSOLVED"}]
2d:["$","h3","h3-10",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Barriers to Digital Pathology Adoption"}]
2e:["$","p","p-3",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"1. Regulatory / Validation Requirements"}]}]
2f:["$","ul","ul-5",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"FDA clearance required for primary diagnosis in US; only a handful of WSI systems have received FDA 510(k) or De Novo clearance (Philips IntelliSite, Leica Aperio GT 450 DX, Hamamatsu NanoZoomer S360MD as of 2024)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"AI algorithms require separate FDA clearance per indication; Paige Prostate (first FDA-cleared AI pathology tool, 2021) took years of clinical validation"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Each lab must perform internal validation studies (CAP/CLIA requirements), typically 60-200 cases per application area, taking 3-6 months per validation"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"International fragmentation: CE-IVD in Europe, PMDA in Japan, NMPA in China -- each with different requirements"}],"\n"]}]
30:["$","p","p-4",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"2. Reimbursement Gaps"}]}]
31:["$","ul","ul-6",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"No specific CPT codes for \"AI-assisted pathology read\" or \"digital pathology primary diagnosis\" -- pathologists are reimbursed the same regardless of methodology"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"CMS has not created differential payment incentives for digital adoption"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"ROI is unclear for many labs: scanning adds cost (~$5-15/slide) without additional reimbursement"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Some payers beginning to explore value-based pathology reimbursement, but adoption is early"}],"\n"]}]
32:["$","p","p-5",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"3. Technology and Infrastructure Challenges"}]}]
33:["$","ul","ul-7",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Scanning throughput:"}]," A single slide takes 60-120 seconds to scan at 40x; a busy lab generating 1,000 slides/day needs 5-10 high-speed scanners ($150K-$300K each)"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Storage:"}]," Each whole slide image (WSI) is 1-3 GB; a medium hospital generates 500K-1M slides/year = 0.5-3 petabytes/year"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Network bandwidth:"}]," Moving multi-GB files requires robust network infrastructure many hospitals lack"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Integration:"}]," WSI systems must integrate with LIS, EHR, and PACS -- interoperability remains poor; DICOM adoption for pathology is still maturing"]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Color calibration:"}]," Staining variability across labs makes AI generalization challenging"]}],"\n"]}]
34:["$","p","p-6",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"4. Pathologist Resistance and Workflow Disruption"}]}]
35:["$","ul","ul-8",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Many pathologists trained on glass slides for decades; digital workflow feels slower initially (studies show 5-15% slower read times during adoption period)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"\"Screen fatigue\" concerns -- reading 60-80 slides/day on a monitor vs. microscope"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Loss of tactile/spatial navigation cues from the microscope"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Trust deficit with AI -- pathologists are legally liable and reluctant to rely on AI recommendations without extensive personal verification"}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":"Cultural resistance: pathology has been one of the most conservative medical specialties in technology adoption"}],"\n"]}]
36:["$","p","p-7",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"5. Economic Misalignment"}]}]
37:["$","ul","ul-9",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Upfront capital investment for full digital conversion: $1.5-5M for a mid-size lab (scanners, storage, software, network upgrades)"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Payback period estimated at 3-7 years, which exceeds many hospital capital planning horizons"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"Benefits accrue system-wide (faster diagnosis, better outcomes) but costs fall on pathology department budgets"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Small/community labs (which represent ~60% of US labs) cannot justify the investment"}],"\n"]}]
38:["$","hr","hr-5",{"className":"my-8 border-neutral-100"}]
39:["$","h2","h2-5",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"6. WILLINGNESS TO PAY SIGNALS"}]
3a:["$","h3","h3-11",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Current Lab Spending on Pathology Technology"}]
3b:["$","div","table-5",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Category"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Price Range"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Notes"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Whole Slide Imaging Scanner"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$150,000 - $350,000 per unit"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Philips, Leica, Hamamatsu, 3DHistech; high-throughput models at premium"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Digital Pathology Software Platform"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$50,000 - $300,000/year (license + maintenance)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Proscia Concentriq, Sectra, Philips, Roche/Ventana"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AI Pathology Tools (per-test pricing)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$20 - $100 per case (AI-assisted read)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Paige, PathAI, Ibex Medical Analytics"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"AI Pathology Tools (enterprise license)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$200,000 - $1M+/year"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Enterprise agreements for high-volume centers"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Outsourced Pathology Reads"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$50 - $300+ per case"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Reference labs, telepathology services"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Locum Pathologist"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$1,500 - $2,500/day"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Temporary staffing agencies"}]]}],["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Pathology LIS System"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$200,000 - $2M (implementation) + $50-200K/year maintenance"}],"$L6a"]}]]}]]}]}]
3c:["$","h3","h3-12",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"VC Investment in Computational Pathology (2020-2025)"}]
3d:["$","div","table-6",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Company"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Total Funding (as of mid-2025)"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Notable Rounds"}],["$","th","th-3",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Key Investors"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Paige AI"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$350-400M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$200M Series C (2024)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Goldman Sachs, Danaher, AMED"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"PathAI"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$400M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$165M Series C (2023)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"General Atlantic, Bristol-Myers Squibb, Merck"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Owkin"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$300M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$180M Series B (2023)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Sanofi, BPI France, Fidelity"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Ibex Medical Analytics"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$75M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$38M Series B (2023)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"aMoon, Planven Entrepreneur Ventures"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Proscia"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$60M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$37M Series B (2022)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Obvious Ventures, Hitachi Ventures"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Nucleai"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$50M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"$$30M Series A (2023)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Debiopharm, aMoon"}]]}],"$L6b","$L6c"]}]]}]}]
3e:["$","p","p-8",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Total VC/growth capital in computational pathology (2020-2025): estimated $2-3 billion+"}]}]
3f:["$","h3","h3-13",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Pharma as Payer"}]
40:["$","ul","ul-10",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"Pharma companies are a major demand signal: spending an estimated $500M-$1B/year on AI-powered pathology for clinical trial companion diagnostics"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"Top 20 pharma companies nearly all have partnerships with computational pathology vendors"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"AstraZeneca, Roche, BMS, Merck, Novartis all have multi-year AI pathology contracts"}],"\n"]}]
41:["$","hr","hr-6",{"className":"my-8 border-neutral-100"}]
42:["$","h2","h2-6",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"7. MARKET GROWTH RATE"}]
43:["$","h3","h3-14",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"CAGR Summary"}]
44:["$","div","table-7",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Market"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"CAGR (2024-2030)"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Source Consensus"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Digital Pathology (overall)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"12-17%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Grand View Research, MarketsandMarkets, Fortune Business Insights"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Computational/AI Pathology"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"30-38%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Precedence Research, Mordor Intelligence, BCC Research"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Whole Slide Imaging Hardware"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"18-22%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Transparency Market Research"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Digital Pathology Software"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"15-20%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Various analyst reports"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Traditional Anatomic Pathology"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"5.5-7.5%"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Allied Market Research, Kalorama"}]]}]]}]]}]}]
45:["$","h3","h3-15",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Growth Catalysts (2025-2030)"}]
46:["$","ul","ul-11",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":"FDA clearance pipeline accelerating: 15+ AI pathology algorithms in FDA review as of 2024"}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"CMS proposed rule for digital pathology reimbursement consideration (2025)"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":"COVID-19 established precedent for remote pathology reads"}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Consolidation of lab networks (Quest, Labcorp, Sonic Healthcare) driving standardization"}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":"EU IVDR implementation pushing digital documentation requirements"}],"\n"]}]
47:["$","hr","hr-7",{"className":"my-8 border-neutral-100"}]
48:["$","h2","h2-7",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"8. KEY PLAYERS TODAY"}]
49:["$","h3","h3-16",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Major Companies in Digital/AI Pathology"}]
4a:["$","div","table-8",{"className":"my-6 overflow-x-auto rounded-lg border border-neutral-200","children":["$","table",null,{"className":"w-full text-sm","children":[["$","thead","thead-0",{"className":"border-b border-neutral-200 bg-neutral-50","children":["$","tr","tr-0",{"className":"bg-white","children":[["$","th","th-0",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Company"}],["$","th","th-1",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Category"}],["$","th","th-2",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Revenue Estimate (2024)"}],["$","th","th-3",{"className":"px-4 py-3 text-left font-medium text-neutral-700","children":"Key Products / Notes"}]]}]}],["$","tbody","tbody-0",{"className":"divide-y divide-neutral-100","children":[["$","tr","tr-0",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Philips (Pathology Solutions)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Hardware + Software"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$300-400M (pathology segment)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"IntelliSite Pathology Solution; first FDA-cleared WSI for primary diagnosis (2017)"}]]}],["$","tr","tr-1",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Leica Biosystems (Danaher)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Hardware + Software"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$2B+ (total, including histology equipment)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Aperio AT2/GT 450 DX scanners; dominant in scanner install base"}]]}],["$","tr","tr-2",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Hamamatsu Photonics"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Hardware"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$150-200M (digital pathology)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"NanoZoomer series; strong in Japan/Europe"}]]}],["$","tr","tr-3",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Roche (Ventana)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"IHC/ISH + Digital"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$2.5B+ (tissue diagnostics division)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"UPATH enterprise software; companion diagnostics leader"}]]}],["$","tr","tr-4",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Paige AI"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI Software"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$30-50M (est. ARR)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"First FDA-cleared AI pathology tool (prostate); expanding to breast, GI"}]]}],["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"PathAI"}]}],"$L6d","$L6e","$L6f"]}],"$L70","$L71","$L72","$L73","$L74","$L75","$L76"]}]]}]}]
4b:["$","h3","h3-17",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Notable M&A Activity (2023-2025)"}]
4c:["$","ul","ul-12",{"className":"list-disc pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Danaher"}]," continued investing in Leica Biosystems digital pathology capabilities"]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Roche"}]," expanded Ventana digital ecosystem"]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Quest Diagnostics"}]," and ",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"Labcorp"}]," both announced digital pathology deployments across reference lab networks (2024)"]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":"Consolidation trend: smaller AI companies being acquired by or partnering with major diagnostics companies"}],"\n"]}]
4d:["$","hr","hr-8",{"className":"my-8 border-neutral-100"}]
4e:["$","h2","h2-8",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"9. KEY SOURCES"}]
4f:["$","h3","h3-18",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Market Research Reports"}]
50:["$","ol","ol-0",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Grand View Research -- \"Digital Pathology Market Size, Share & Trends Analysis Report\" (2024): ",["$","a","a-0",{"href":"https://www.grandviewresearch.com/industry-analysis/digital-pathology-market","children":"https://www.grandviewresearch.com/industry-analysis/digital-pathology-market"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["MarketsandMarkets -- \"Digital Pathology Market\" (2024): ",["$","a","a-0",{"href":"https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-11282637.html","children":"https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-11282637.html"}]]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["Fortune Business Insights -- \"Digital Pathology Market\" (2024): ",["$","a","a-0",{"href":"https://www.fortunebusinessinsights.com/digital-pathology-market-102601","children":"https://www.fortunebusinessinsights.com/digital-pathology-market-102601"}]]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["Precedence Research -- \"Computational Pathology Market\" (2024): ",["$","a","a-0",{"href":"https://www.precedenceresearch.com/computational-pathology-market","children":"https://www.precedenceresearch.com/computational-pathology-market"}]]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":["Allied Market Research -- \"Anatomic Pathology Market\" (2023): ",["$","a","a-0",{"href":"https://www.alliedmarketresearch.com/anatomical-pathology-market","children":"https://www.alliedmarketresearch.com/anatomical-pathology-market"}]]}],"\n",["$","li","li-5",{"className":"leading-relaxed","children":["Mordor Intelligence -- \"AI in Pathology Market\" (2024): ",["$","a","a-0",{"href":"https://www.mordorintelligence.com/industry-reports/ai-in-pathology-market","children":"https://www.mordorintelligence.com/industry-reports/ai-in-pathology-market"}]]}],"\n"]}]
51:["$","h3","h3-19",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Workforce and Professional Organization Data"}]
52:["$","ol","ol-1",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["ASCP -- \"2023-2024 Vacancy Survey of Medical Laboratories\": ",["$","a","a-0",{"href":"https://www.ascp.org/content/get-involved/wage-survey","children":"https://www.ascp.org/content/get-involved/wage-survey"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["College of American Pathologists (CAP) -- Workforce resources: ",["$","a","a-0",{"href":"https://www.cap.org/advocacy/cap-priorities/pathologist-workforce","children":"https://www.cap.org/advocacy/cap-priorities/pathologist-workforce"}]]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["NRMP -- National Resident Matching Program data: ",["$","a","a-0",{"href":"https://www.nrmp.org/match-data-analytics/residency-data-reports/","children":"https://www.nrmp.org/match-data-analytics/residency-data-reports/"}]]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["The Pathologist -- \"The Staffing Crisis\" (2024): ",["$","a","a-0",{"href":"https://thepathologist.com/","children":"https://thepathologist.com/"}]]}],"\n"]}]
53:["$","h3","h3-20",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Clinical Evidence and Medical Literature"}]
54:["$","ol","ol-2",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Hanna TP, et al. -- \"Mortality due to cancer treatment delay: systematic review and meta-analysis.\" BMJ 2020;371:m4087: ",["$","a","a-0",{"href":"https://doi.org/10.1136/bmj.m4087","children":"https://doi.org/10.1136/bmj.m4087"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["NCI SEER Program -- Cancer statistics and stage-specific survival/cost data: ",["$","a","a-0",{"href":"https://seer.cancer.gov/","children":"https://seer.cancer.gov/"}]]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["Milliman -- Cancer treatment cost analyses: ",["$","a","a-0",{"href":"https://www.milliman.com/","children":"https://www.milliman.com/"}]]}],"\n"]}]
55:["$","h3","h3-21",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Malpractice and Legal"}]
56:["$","ol","ol-3",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Coverys -- \"Closing the Gap\" diagnostic error study (2023): ",["$","a","a-0",{"href":"https://www.coverys.com/knowledge-center/closing-the-gap","children":"https://www.coverys.com/knowledge-center/closing-the-gap"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["CRICO Strategies -- Comparative Benchmarking System malpractice data: ",["$","a","a-0",{"href":"https://www.rmf.harvard.edu/","children":"https://www.rmf.harvard.edu/"}]]}],"\n"]}]
57:["$","h3","h3-22",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"Industry and News Sources"}]
58:["$","ol","ol-4",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Dark Daily -- Laboratory and pathology industry news: ",["$","a","a-0",{"href":"https://www.darkdaily.com/","children":"https://www.darkdaily.com/"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":["GenomeWeb / 360Dx -- Diagnostics and pathology business coverage: ",["$","a","a-0",{"href":"https://www.genomeweb.com/","children":"https://www.genomeweb.com/"}]]}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["Digital Pathology Association: ",["$","a","a-0",{"href":"https://digitalpathologyassociation.org/","children":"https://digitalpathologyassociation.org/"}]]}],"\n",["$","li","li-3",{"className":"leading-relaxed","children":["Paige AI: ",["$","a","a-0",{"href":"https://paige.ai/","children":"https://paige.ai/"}]]}],"\n",["$","li","li-4",{"className":"leading-relaxed","children":["PathAI: ",["$","a","a-0",{"href":"https://www.pathai.com/","children":"https://www.pathai.com/"}]]}],"\n",["$","li","li-5",{"className":"leading-relaxed","children":["Proscia: ",["$","a","a-0",{"href":"https://www.proscia.com/","children":"https://www.proscia.com/"}]]}],"\n"]}]
59:["$","h3","h3-23",{"className":"text-base font-medium text-neutral-800 mt-10 mb-3","children":"VC and Funding Data"}]
5a:["$","ol","ol-5",{"className":"list-decimal pl-5 space-y-2 text-[0.9375rem] text-neutral-600 mb-4","children":["\n",["$","li","li-0",{"className":"leading-relaxed","children":["Crunchbase -- Company funding profiles: ",["$","a","a-0",{"href":"https://www.crunchbase.com/","children":"https://www.crunchbase.com/"}]]}],"\n",["$","li","li-1",{"className":"leading-relaxed","children":"PitchBook -- Private market data on computational pathology companies"}],"\n",["$","li","li-2",{"className":"leading-relaxed","children":["CB Insights -- AI in Healthcare report (2024): ",["$","a","a-0",{"href":"https://www.cbinsights.com/","children":"https://www.cbinsights.com/"}]]}],"\n"]}]
5b:["$","hr","hr-9",{"className":"my-8 border-neutral-100"}]
5c:["$","h2","h2-9",{"className":"text-xl font-semibold text-neutral-900 mt-14 mb-4 scroll-mt-28","children":"EXECUTIVE SUMMARY"}]
5d:["$","p","p-9",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["The pathology lab backlog problem represents a ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"$$8-15 billion annual economic burden"}]," in the US alone, driven by a structural pathologist workforce shortage that is worsening by 150-250 net pathologists per year. With ~13,000-14,000 active anatomic pathologists reading 300-400 million slides annually, the system is operating at or beyond capacity, resulting in multi-week diagnostic delays that measurably increase cancer mortality and stage-at-diagnosis."]}]
5e:["$","p","p-10",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":["The ",["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"digital pathology market (~$1.2-1.5B in 2024)"}]," is growing at 12-17% CAGR, while the ",["$","strong","strong-1",{"className":"font-semibold text-neutral-800","children":"AI/computational pathology subsegment (~$600-800M)"}]," is growing at 30-38% CAGR, making this one of the fastest-growing segments in diagnostics. Over ",["$","strong","strong-2",{"className":"font-semibold text-neutral-800","children":"$$2-3 billion in VC capital"}]," has flowed into the space since 2020, with Paige AI, PathAI, and Owkin each raising $300M+."]}]
5f:["$","p","p-11",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":"Despite this investment, adoption remains limited due to: (1) regulatory burden requiring per-indication FDA clearance, (2) no reimbursement differential for digital reads, (3) $1.5-5M upfront capital costs per lab, (4) massive data storage requirements (~1-3 PB/year per medium hospital), and (5) pathologist cultural resistance. The market is at an inflection point, however, with accelerating FDA clearances, pharma demand for AI-powered companion diagnostics, and the COVID-era normalization of remote reads creating strong tailwinds."}]
60:["$","p","p-12",{"className":"text-[0.9375rem] leading-relaxed text-neutral-600 mb-4","children":[["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"The projected pathologist deficit of 5,000-6,000 by 2030 makes this problem structurally unsolvable through hiring alone"}],", creating a durable market opportunity for AI-augmented pathology solutions that can increase per-pathologist throughput by 2-5x while maintaining or improving diagnostic accuracy."]}]
61:["$","div",null,{"className":"mt-16 flex flex-wrap items-center gap-4 border-t border-neutral-100 pt-8","children":[["$","$Le",null,{"href":"/reports/market-opportunity-research","className":"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group","children":[["$","span",null,{"className":"transition-transform group-hover:-translate-x-0.5","children":"â"}],"Back to AI Market Opportunity Research"]}],["$","span",null,{"className":"text-neutral-300","children":"Â·"}],["$","$Le",null,{"href":"/research","className":"inline-flex items-center gap-1.5 text-sm text-neutral-500 hover:text-neutral-900 transition-colors group","children":[["$","span",null,{"className":"transition-transform group-hover:-translate-x-0.5","children":"â"}],"Back to Research"]}]]}]
62:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.8B by 2030"}]
63:["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"7-8%"}]
64:["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"MarketsandMarkets (2024)"}]
65:["$","tr","tr-5",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Whole Slide Imaging (WSI) Scanners"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$500-700 million"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$1.8-2.2B by 2030"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"18-22%"}],["$","td","td-4",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Transparency Market Research (2024)"}]]}]
66:["$","tr","tr-7",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Projected shortage by 2030"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Deficit of 5,000-6,000 pathologists (relative to demand)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"The Pathologist, ASCP workforce modeling"}]]}]
67:["$","tr","tr-8",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Average slides per pathologist per day"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"60-80 slides/day (typical); some subspecialties 30-50; high-volume cytology up to 100+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"CAP workload guidelines"}]]}]
68:["$","tr","tr-9",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Recommended maximum (CAP)"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Not formally capped, but studies suggest quality declines above ~70-80 complex surgical path slides/day"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Published literature on diagnostic error rates"}]]}]
69:["$","tr","tr-10",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Pathologist vacancy rate"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"9-12% of positions unfilled nationally; 15-20%+ in rural/community hospitals"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"ASCP 2024 Vacancy Survey"}]]}]
6a:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Cerner, Epic Beaker, Sunquest, Orchard"}]
6b:["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Lunit"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$200M+ (post-IPO)"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"IPO on KOSDAQ (2022); additional capital raises"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Public markets"}]]}]
6c:["$","tr","tr-7",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Deep Bio"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$30M+"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Series B (2023)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Various Korean VCs"}]]}]
6d:["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI Software + Pharma Services"}]
6e:["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$50-80M (est. ARR)"}]
6f:["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AISight platform; strong pharma services revenue; partnerships with Labcorp, BMS"}]
70:["$","tr","tr-6",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Proscia"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Digital Pathology Platform"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$15-25M (est. ARR)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Concentriq platform; focus on enterprise digital pathology workflow"}]]}]
71:["$","tr","tr-7",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Ibex Medical Analytics"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI Software"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$10-20M (est. ARR)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Galen platform; CE-IVD marked for multiple cancer types; deployed in Europe/Israel"}]]}]
72:["$","tr","tr-8",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Lunit"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI Software"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$50-80M (revenue, public company)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"SCOPE suite; partnerships with Guardant, strong in Asia"}]]}]
73:["$","tr","tr-9",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"3DHistech"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Hardware"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$50-80M (est.)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"PANNORAMIC scanners; strong in Europe/academic"}]]}]
74:["$","tr","tr-10",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Sectra"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Digital Pathology IT"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$30-50M (pathology segment)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Enterprise imaging platform with pathology module"}]]}]
75:["$","tr","tr-11",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Inspirata"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Informatics"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$20-30M (est.)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Comprehensive cancer informatics; acquired by Roper Technologies"}]]}]
76:["$","tr","tr-12",{"className":"bg-white","children":[["$","td","td-0",{"className":"px-4 py-3 text-neutral-600 align-top","children":["$","strong","strong-0",{"className":"font-semibold text-neutral-800","children":"Owkin"}]}],["$","td","td-1",{"className":"px-4 py-3 text-neutral-600 align-top","children":"AI Research Platform"}],["$","td","td-2",{"className":"px-4 py-3 text-neutral-600 align-top","children":"~$20-40M (est. ARR)"}],["$","td","td-3",{"className":"px-4 py-3 text-neutral-600 align-top","children":"Federated learning for pathology; strong pharma partnerships"}]]}]
a:[["$","meta","0",{"charSet":"utf-8"}],["$","meta","1",{"name":"viewport","content":"width=device-width, initial-scale=1"}]]
77:I[27201,["/rigidbodydynamicsai/_next/static/chunks/ff1a16fafef87110.js","/rigidbodydynamicsai/_next/static/chunks/d2be314c3ece3fbe.js"],"IconMark"]
8:null
c:[["$","title","0",{"children":"Pathology Lab Backlog â AI Market Opportunity Research"}],["$","meta","1",{"name":"description","content":"Multi-week backlogs delay cancer diagnoses due to pathologist shortage and manual slide reading. Economic cost of delayed diagnosis and shortage is $50â100B+/yr; digital/AI pathology is the fastest-growing segment."}],["$","meta","2",{"property":"og:title","content":"Rigid Body Dynamics AI â AI That Does the Work for You"}],["$","meta","3",{"property":"og:description","content":"We research what's next in AI and make it accessible â one problem at a time."}],["$","meta","4",{"name":"twitter:card","content":"summary"}],["$","meta","5",{"name":"twitter:title","content":"Rigid Body Dynamics AI â AI That Does the Work for You"}],["$","meta","6",{"name":"twitter:description","content":"We research what's next in AI and make it accessible â one problem at a time."}],["$","link","7",{"rel":"icon","href":"/rigidbodydynamicsai/favicon.ico?favicon.0b3bf435.ico","sizes":"256x256","type":"image/x-icon"}],["$","link","8",{"rel":"icon","href":"/icon?64afa28a3da3d704","alt":"$undefined","type":"image/png","sizes":"32x32"}],["$","$L77","9",{}]]
